Oncostatin M is a novel glucocorticoid-dependent neuroinflammatory factor that enhances oligodendrocyte precursor cell activity in demyelinated sites

Brain, Behavior, and Immunity

Volumn 24, Issue 5, 2010, Pages 695-704

  Glezer, Isaias ^a   Rivest, Serge ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Brain repair; Demyelination; Glucocorticoids; Gp130; Lipopolysaccharide; Neuroprotection; Olig bHLH transcription factors

Indexed keywords

CYTOKINE; ENDOTOXIN; GLUCOCORTICOID; GLYCOPROTEIN GP 130; LIPOPOLYSACCHARIDE; MIFEPRISTONE; MYELIN; ONCOSTATIN M; ONCOSTATIN M RECEPTOR; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ASTROCYTE; CELL MOTILITY; CELL SURVIVAL; CONTROLLED STUDY; DEMYELINATION; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; INNATE IMMUNITY; MALE; MOUSE; NEGATIVE FEEDBACK; NERVE CELL; NERVE CELL DIFFERENTIATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; TISSUE REPAIR; TRANSCRIPTION INITIATION;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; BRAIN; CELL LINE; CELLS, CULTURED; DEMYELINATING DISEASES; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; MICE; OLIGODENDROGLIA; ONCOSTATIN M; RECEPTORS, GLUCOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77953613542     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.01.005     Document Type: Review

References (58)

1. Aharonowiz M., Einstein O., Fainstein N., Lassmann H., Reubinoff B., Ben-Hur T. Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis. PLoS One 2008, 3:e3145.
2. Arnett H.A., Fancy S.P., Alberta J.A., Zhao C., Plant S.R., Kaing S., Raine C.S., Rowitch D.H., Franklin R.J., Stiles C.D. BHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 2004, 306:2111-2115.
3. Baker B.J., Qin H., Benveniste E.N. Molecular basis of oncostatin M-induced SOCS-3 expression in astrocytes. Glia 2008, 56:1250-1262.
4. Bauer S., Kerr B.J., Patterson P.H. The neuropoietic cytokine family in development, plasticity, disease and injury. Nat. Rev. Neurosci. 2007, 8:221-232.
5. Butzkueven H., Zhang J.G., Soilu-Hanninen M., Hochrein H., Chionh F., Shipham K.A., Emery B., Turnley A.M., Petratos S., Ernst M., Bartlett P.F., Kilpatrick T.J. LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat. Med. 2002, 8:613-619.
6. Chen S.H., Benveniste E.N. Oncostatin M: a pleiotropic cytokine in the central nervous system. Cytokine Growth Factor Rev. 2004, 15:379-391.
7. Covacu R., Arvidsson L., Andersson A., Khademi M., Erlandsson-Harris H., Harris R.A., Svensson M.A., Olsson T., Brundin L. TLR activation induces TNF-alpha production from adult neural stem/progenitor cells. J. Immunol. 2009, 182:6889-6895.
8. Einstein O., Friedman-Levi Y., Grigoriadis N., Ben-Hur T. Transplanted neural precursors enhance host brain-derived myelin regeneration. J. Neurosci. 2009, 29:15694-15702.
9. Franklin R.J., Ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 2008, 9:839-855.
10. Gensert J.M., Goldman J.E. Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron 1997, 19:197-203.
11. Gillespie L.N., Clark G.M., Bartlett P.F., Marzella P.L. LIF is more potent than BDNF in promoting neurite outgrowth of mammalian auditory neurons in vitro. Neuroreport 2001, 12:275-279.
12. Glezer I., Chernomoretz A., David S., Plante M.M., Rivest S. Genes involved in the balance between neuronal survival and death during inflammation. PLoS One 2007, 2:e310.
13. Glezer I., Lapointe A., Rivest S. Innate immunity triggers oligodendrocyte progenitor reactivity and confines damages to brain injuries. FASEB J 2006, 20:750-752.
14. Glezer I., Rivest S. Glucocorticoids: protectors of the brain during innate immune responses. Neuroscientist 2004, 10:538-552.
15. Glezer I., Simard A.R., Rivest S. Neuroprotective role of the innate immune system by microglia. Neuroscience 2007, 147:867-883.
16. Glezer I., Zekki H., Scavone C., Rivest S. Modulation of the innate immune response by NMDA receptors has neuropathological consequences. J. Neurosci. 2003, 23:11094-11103.
17. Goren I., Kampfer H., Muller E., Schiefelbein D., Pfeilschifter J., Frank S. Oncostatin M expression is functionally connected to neutrophils in the early inflammatory phase of skin repair: implications for normal and diabetes-impaired wounds. J. Invest. Dermatol. 2006, 126:628-637.
18. Graca D.L., Blakemore W.F. Delayed remyelination in rat spinal cord following ethidium bromide injection. Neuropathol. Appl. Neurobiol. 1986, 12:593-605.
19. Grenier A., Dehoux M., Boutten A., Arce-Vicioso M., Durand G., Gougerot-Pocidalo M.A., Chollet-Martin S. Oncostatin M production and regulation by human polymorphonuclear neutrophils. Blood 1999, 93:1413-1421.
20. Ip N.Y., Nye S.H., Boulton T.G., Davis S., Taga T., Li Y., Birren S.J., Yasukawa K., Kishimoto T., Anderson D.J. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 1992, 69:1121-1132.
21. Kang H.J., Kang J.S., Lee S.H., Hwang S.J., Chae S.W., Woo J.S., Lee H.M. Upregulation of oncostatin M in allergic rhinitis. Laryngoscope 2005, 115:2213-2216.
22. Krona A., Aman P., Orndal C., Josefsson A. Oncostatin M-induced genes in human astrocytomas. Int. J. Oncol. 2007, 31:1457-1463.
23. Lacroix S., Feinstein D., Rivest S. The bacterial endotoxin lipopolysaccharide has the ability to target the brain in upregulating its membrane CD14 receptor within specific cellular populations. Brain Pathol. 1998, 8:625-640.
24. Laflamme N., Lacroix S., Rivest S. An essential role of interleukin-1beta in mediating NF-kappaB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia. J. Neurosci. 1999, 19:10923-10930.
25. Larsen P.H., Wells J.E., Stallcup W.B., Opdenakker G., Yong V.W. Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan. J. Neurosci. 2003, 23:11127-11135.
26. Leclerc N., Luppen C.A., Ho V.V., Nagpal S., Hacia J.G., Smith E., Frenkel B. Gene expression profiling of glucocorticoid-inhibited osteoblasts. J. Mol. Endocrinol. 2004, 33:175-193.
27. Lu Q.R., Cai L., Rowitch D., Cepko C.L., Stiles C.D. Ectopic expression of Olig1 promotes oligodendrocyte formation and reduces neuronal survival in developing mouse cortex. Nat. Neurosci. 2001, 4:973-974.
28. Luu-The V., Paquet N., Calvo E., Cumps J. Improved real-time RT-PCR method for high-throughput measurements using second derivative calculation and double correction. Biotechniques 2005, 38:287-293.
29. McMaster A., Ray D.W. Drug insight: selective agonists and antagonists of the glucocorticoid receptor. Nat. Clin. Pract. Endocrinol. Metab. 2008, 4:91-101.
30. Modur V., Feldhaus M.J., Weyrich A.S., Jicha D.L., Prescott S.M., Zimmerman G.A., McIntyre T.M. Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules. J. Clin. Invest. 1997, 100:158-168.
31. Murphy M., Dutton R., Koblar S., Cheema S., Bartlett P. Cytokines which signal through the LIF receptor and their actions in the nervous system. Prog. Neurobiol. 1997, 52:355-378.
32. Nadeau S., Rivest S. Glucocorticoids play a fundamental role in protecting the brain during innate immune response. J. Neurosci. 2003, 23:5536-5544.
33. Nakashima K., Wiese S., Yanagisawa M., Arakawa H., Kimura N., Hisatsune T., Yoshida K., Kishimoto T., Sendtner M., Taga T. Developmental requirement of gp130 signaling in neuronal survival and astrocyte differentiation. J. Neurosci. 1999, 19:5429-5434.
34. Nimmerjahn A., Kirchhoff F., Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308:1314-1318.
35. O'Neill L.A. When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction. Immunity 2008, 29:12-20.
36. Ogawa S., Lozach J., Benner C., Pascual G., Tangirala R.K., Westin S., Hoffmann A., Subramaniam S., David M., Rosenfeld M.G., Glass C.K. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 2005, 122:707-721.
37. Panickar K.S., Norenberg M.D. Astrocytes in cerebral ischemic injury: morphological and general considerations. Glia 2005, 50:287-298.
38. Paxinos G., Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates 2001, Academic Press, San Diego.
39. Rivest S. Regulation of innate immune responses in the brain. Nat. Rev. Immunol. 2009, 9:429-439.
40. Rowitch D.H. Glial specification in the vertebrate neural tube. Nat. Rev. Neurosci. 2004, 5:409-419.
41. Ruprecht K., Kuhlmann T., Seif F., Hummel V., Kruse N., Bruck W., Rieckmann P. Effects of oncostatin M on human cerebral endothelial cells and expression in inflammatory brain lesions. J. Neuropathol. Exp. Neurol. 2001, 60:1087-1098.
42. Sikorski E.E., Hallmann R., Berg E.L., Butcher E.C. The Peyer's patch high endothelial receptor for lymphocytes, the mucosal vascular addressin, is induced on a murine endothelial cell line by tumor necrosis factor-alpha and IL-1. J. Immunol. 1993, 151:5239-5250.
43. Sim F.J., Hinks G.L., Franklin R.J. The re-expression of the homeodomain transcription factor Gtx during remyelination of experimentally induced demyelinating lesions in young and old rat brain. Neuroscience 2000, 100:131-139.
44. Smyth D.C., Kerr C., Richards C.D. Oncostatin M-induced IL-6 expression in murine fibroblasts requires the activation of protein kinase Cdelta. J. Immunol. 2006, 177:8740-8747.
45. Soulet D., Rivest S. Polyamines play a critical role in the control of the innate immune response in the mouse central nervous system. J. Cell Biol. 2003, 162:257-268.
46. Spitz I.M., Bardin C.W. Mifepristone (RU 486) - a modulator of progestin and glucocorticoid action. N. Engl. J. Med. 1993, 329:404-412.
47. Stankoff B., Aigrot M.S., Noel F., Wattilliaux A., Zalc B., Lubetzki C. Ciliary neurotrophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules. J. Neurosci. 2002, 22:9221-9227.
48. Takebayashi H., Nabeshima Y., Yoshida S., Chisaka O., Ikenaka K., Nabeshima Y. The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages. Curr. Biol. 2002, 12:1157-1163.
49. Tanaka M., Miyajima A. Oncostatin M, a multifunctional cytokine. Rev. Physiol. Biochem. Pharmacol. 2003, 149:39-52.
50. Van Wagoner N.J., Choi C., Repovic P., Benveniste E.N. Oncostatin M regulation of interleukin-6 expression in astrocytes: biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38. J. Neurochem. 2000, 75:563-575.
51. Villeneuve J., Galarneau H., Beaudet M.J., Tremblay P., Chernomoretz A., Vallieres L. Reduced glioma growth following dexamethasone or anti-angiopoietin 2 treatment. Brain Pathol. 2008, 18:401-414.
52. Weiss T.W., Samson A.L., Niego B., Daniel P.B., Medcalf R.L. Oncostatin M is a neuroprotective cytokine that inhibits excitotoxic injury in vitro and in vivo. FASEB J. 2006, 20:2369-2371.
53. Weiss T.W., Speidl W.S., Kaun C., Rega G., Springer C., Macfelda K., Losert U.M., Grant S.L., Marro M.L., Rhodes A.D., Fuernkranz A., Bialy J., Ullrich R., Holzmann P., Pacher R., Maurer G., Huber K., Wojta J. Glycoprotein 130 ligand oncostatin-M induces expression of vascular endothelial growth factor in human adult cardiac myocytes. Cardiovasc. Res. 2003, 59:628-638.
54. Wolswijk G. Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain 2002, 125:338-349.
55. Xin M., Yue T., Ma Z., Wu F.F., Gow A., Lu Q.R. Myelinogenesis and axonal recognition by oligodendrocytes in brain are uncoupled in Olig1-null mice. J. Neurosci. 2005, 25:1354-1365.
56. Yajima K., Suzuki K. Demyelination and remyelination in the rat central nervous system following ethidium bromide injection. Lab. Invest. 1979, 41:385-392.
57. Zhang Y., Taveggia C., Melendez-Vasquez C., Einheber S., Raine C.S., Salzer J.L., Brosnan C.F., John G.R. Interleukin-11 potentiates oligodendrocyte survival and maturation, and myelin formation. J. Neurosci. 2006, 26:12174-12185.
58. Zhou Q., Choi G., Anderson D.J. The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2. Neuron 2001, 31:791-807.